NCT06072833 2026-03-16
Characterizing and Addressing Financial Toxicity in AYAs With Cancer
Columbia University
Phase NA Completed
Clinical Trials
173 trialsNCT04913259 2026-03-03
TS-PAC
Institut Bergonié
Phase NA Active not recruiting
NCT05148078 2026-03-02
Pediatric Radiation Oncology With Movie Induced Sedation Effect (PROMISE)
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT05024968 2026-02-25
Sintilimab in Cancer of Unknown Primary
M.D. Anderson Cancer Center
Phase 2 Completed
NCT06837090 2026-02-20
SPAINTRK
Grupo Espanol de Tumores Neuroendocrinos
Completed
NCT04150900 2026-02-19
1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck
University of Maryland, Baltimore
Phase 2 Active not recruiting
NCT03388190 2026-02-13
METIMMOX
University Hospital, Akershus
Phase 2 Completed
NCT03436290 2026-01-28
SCOPE
Vanderbilt University Medical Center
Phase NA Active not recruiting
NCT03824158 2026-01-14
Patient-centered and Efficacious Advance Care Planning in Cancer: the PEACe Comparative Effectiveness Trial
University of Pittsburgh
Phase NA Completed
NCT06013176 2025-12-29
BEST-PRO
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT03473652 2025-12-15
APPAHOCA
Centre Francois Baclesse
Phase NA Completed
NCT03676010 2025-12-10
DATECAN-1
Institut Bergonié
Active not recruiting
NCT04021043 2025-12-03
BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT04266912 2025-11-25
Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors
M.D. Anderson Cancer Center
Phase 1/2 Active not recruiting
NCT05847686 2025-11-05
Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer
University of Washington
Phase 1/2 Completed
NCT04010240 2025-10-16
NTRK
Institut Bergonié
Completed
NCT02874001 2025-10-06
PO-BADO
Institut Bergonié
Completed
NCT03963518 2025-10-06
SURROGATE-ICI
Institut Bergonié
Completed
NCT03676218 2025-10-03
DATECANelderly
Institut Bergonié
Completed
NCT03694171 2025-10-03
Access to Care and Prognosis in Elderly With Cancer (INCAPAC Study)
Institut Bergonié
Completed
NCT04614662 2025-09-23
Symptom Screening Linked to Care Pathways
The Hospital for Sick Children
Phase NA Completed
NCT06648161 2025-09-09
Using a Mirror in the Second Stage of Labor: Effects on Duration and Birth Experience
Kocaeli University
Phase NA Completed
NCT02751827 2025-08-24
PreToxE
Institut Bergonié
Completed
NCT06561217 2025-07-25
Assessing the Performance of Artificial Intelligence (AI)-Augmented Electronic Health Record (EHR) Data Abstraction for Clinical Trial Patient Screening
University of Pennsylvania
Completed
NCT04939246 2025-07-17
SMART ONE
Baptist Health South Florida
Phase NA Completed
NCT04808999 2025-05-29
Neoadjuvant Study of PD-1 Inhibitor Pembrolizumab in PD-1 Naive Cutaneous Squamous Cell Carcinoma (cSCC)
University of Pittsburgh
Phase 2 Active not recruiting
NCT01369641 2025-05-16
The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy
Thomas Jefferson University
Phase NA Terminated
NCT01871441 2025-05-16
Haploidentical Donor Hematopoietic Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Thomas Jefferson University
Phase 2 Terminated
NCT02751580 2025-05-16
Telehealth in Improving Quality of Life in Patients During Post Radiation Therapy Visits
Thomas Jefferson University
Phase NA Completed
NCT04257058 2025-05-15
Education Tools to Support Pediatric Survivor Care
Emory University
Phase NA Completed
NCT03570619 2025-05-08
IMPACT
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT02770326 2025-04-08
Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT03578081 2025-04-06
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT05235750 2025-03-17
Self-affirmation Intervention for People Newly Diagnosed With Advanced Cancer
University of Arkansas
Phase NA Completed
NCT03752203 2025-03-06
Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical Tumors
University of Colorado, Denver
Phase NA Terminated
NCT03737058 2025-02-27
Lay Health Worker Led Symptom Assessment Intervention
Stanford University
Completed
NCT03857620 2025-02-21
Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer
Alliance for Clinical Trials in Oncology
Phase NA Active not recruiting
NCT05590962 2025-02-06
Predictive Analytics and Behavioral Nudges to Improve Palliative Care in Advanced Cancer
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT05365997 2025-02-05
BE-EPiC
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT03839940 2025-01-29
MIST
Alliance for Clinical Trials in Oncology
Phase 3 Terminated
NCT03406871 2025-01-24
REGONIVO
National Cancer Center Hospital East
Phase 1 Completed
NCT03249090 2025-01-14
PRO-TECT
Alliance Foundation Trials, LLC.
Phase NA Completed
NCT04187833 2025-01-14
Nivolumab in Combination With Talazoparib in Melanoma and Mutations in BRCA or BRCA-ness Genes
Case Comprehensive Cancer Center
Phase 2 Completed
NCT03599661 2025-01-09
Developing and Validating Fertilit-e
Wake Forest University Health Sciences
Terminated
NCT06191679 2025-01-06
DECIDES B+
Children's Hospital of Philadelphia
Phase NA Completed
NCT04376502 2025-01-03
Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma.
Baptist Health South Florida
Phase NA Terminated
NCT05505045 2024-12-16
Metacognitive Strategy Training in Cancer-related Cognitive Impairment
University of Missouri-Columbia
Phase NA Completed
NCT01870505 2024-12-09
BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT05478135 2024-11-08
A Remote Evaluation of NAVIFY Oncology Hub Using Clinical Simulation
Prova Health Limited
Phase NA Completed
NCT03296137 2024-10-26
Adoptive Cell Therapy Across Cancer Diagnoses
Herlev Hospital
Phase 1/2 Completed